Patients with diabetes will typically experience frequent urination (polyuria), increased thirst (polydipsia) and increased hunger (polyphagia). If diabetes is not controlled, it can lead to serious health complications including heart diseases, kidney diseases, stroke, amputations of the legs and feet, blindness and early death.
The diabetes market is majorly driven by the rise in the number of people with diabetes, complexities in alternative diabetes therapy and strong encouragement from the Governments. However, the lack of proper regulatory framework, lack of public awareness of the disease and cost sensitivity issues are hindering the growth of the market.
The diabetes market can be segmented into diabetes care devices: glucose monitoring devices and insulin delivery devices; and therapy type: injectable and oral drugs. Glucose monitoring devices has been further segmented into blood glucose meters, blood glucose test strips, lancing devices, continuous glucose monitoring devices. Insulin delivery devices are also sub segmented into insulin pump, insulin syringe and insulin pen.
The diabetes market can be geographically segmented into Asia Pacific, Europe, North America, and Rest of the World, with North America dominating the global market currently. Asia Pacific is also an emerging market which has a scope for growth and can potentially dominate the market in the future.
Market analysis for the global diabetes market, with region specific assessments and competition analysis on global and regional scales.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market shares.
Identification and analysis of the macro and micro factors that affect the global diabetes market on both global and regional scales.
A comprehensive list of key market players along with the analysis of their current strategic interests.
1.1 Report Description
1.2 Research Methodology
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
3. MARKET OVERVIEW
3.1 Market Definition
3.2 Market Segmentation
3.2.1 Diabetes Care Devices
18.104.22.168 Glucose Monitoring Devices
22.214.171.124.1 Blood Glucose Meters
126.96.36.199.2 Blood Glucose Test Strips
188.8.131.52.3 Lancing Devices
184.108.40.206.4 Continuous Glucose Monitoring Devices
220.127.116.11 Insulin Delivery Devices
18.104.22.168.1 Insulin Pumps
22.214.171.124.3 Insulin Syringes
126.96.36.199.4 Insulin Pens
3.2.2 Therapy Type
188.8.131.52 Oral Drugs
184.108.40.206 Asia Pacific
220.127.116.11 North America
18.104.22.168 Rest of the World
3.3 Market Drivers
3.3.1 Rise in number of people with diabetes
3.3.2 Complexities in alternative diabetes therapy
3.3.3 Government Initiatives
3.4 Market Challenges
3.4.1 Regulatory Framework
3.4.2 Low awareness
3.4.3 Cost sensitivity
4. NORTH AMERICA MARKETS: SEGMENTATION BY DRUGS
4.1 Insulin Derivatives
4.1.1 Rapid acting insulin
4.1.2 Intermediate acting insulin
4.1.3 Long acting insulin
4.2 Oral Diabetic Medication Drugs
4.2.3 Alpha-Glucosidace inhibitor
5. NORTH AMERICAN MARKETS: SEGMENTATION BY GEOGRAPHY
6. COMPETITIVE LANDSCAPE
6.2 Mergers & Acquisitions
6.4 New Product Launch
7. COMPANY PROFILES
7.1 Abbott Laboratories
7.2 Dexcom Inc.
7.3 Johnson & Johnson
7.4 Merck & Co.